Results 131 to 140 of about 10,931 (234)

Adenovirus Vector‐Mediated In Vivo Knock‐in Treatment of Neonatal Phenylketonuria Mice Using Terminally Cleaved Donor DNA

open access: yesThe Journal of Gene Medicine, Volume 28, Issue 8, August 2026.
We successfully developed a highly efficient knock‐in adenovirus vector, AxPah‐6g‐cut. This vector cleaves not only the genomic target site but also the terminus of the donor DNA in the vector. When this vector was intravenously administered twice to phenylketonuria (Pahenu2) mice together with a Cas9‐expressing vector, AxCBCas9, it resulted in the ...
Megumi Yamaji   +10 more
wiley   +1 more source

Polish Brachytherapy Society clinical recommendations and expert consensus on radical high-dose-rate brachytherapy for prostate cancer. [PDF]

open access: yesJ Contemp Brachytherapy
Chyrek AJ   +24 more
europepmc   +1 more source

A multidisciplinary experimental and methodological investigation of electron and proton minibeams in the framework of the INFN MIRO project

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
Abstract Background The clinical translation of Minibeam RT (MBRT) has recently started thanks to the first human treatments recently performed. However, despite experimental evidence, the impact of the dose distribution parameters involved on the magnitude of the effect itself and the underlying radiobiological mechanisms are still only partially ...
Francesco Romano   +89 more
wiley   +1 more source

Trends in brachytherapy utilization in Canada from 2011 to 2020. [PDF]

open access: yesPhys Imaging Radiat Oncol
Dumančić M   +15 more
europepmc   +1 more source

Lighting up FLASH and beyond: TLD response across four orders of magnitude in proton dose rate

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
ABSTRACT Background Thermoluminescent dosimeters (TLDs) are widely used for proton therapy dosimetry and remote audits. Yet their response under pulsed delivery and the ultrahigh dose rates relevant to proton FLASH remains incompletely characterized.
Fada Guan   +10 more
wiley   +1 more source

Automated dual-camera DMD system for stereo optical sectioning imaging. [PDF]

open access: yesBiomed Opt Express
Jiménez-Villar A   +5 more
europepmc   +1 more source

Feasibility of convection‐enhanced delivery of unlabeled 225Ac for glioblastoma: Transport, dosimetry, and clonogenic survival modeling

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Glioblastoma (GB) is an aggressive primary brain tumor with local recurrence rates exceeding 90% and a five‐year survival rate of approximately 5%. Standard treatments such as surgical resection, external beam radiotherapy (EBRT), and chemotherapy often leave residual tumor cells that are resistant to therapy.
Maram El Sabri   +4 more
wiley   +1 more source

Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images. [PDF]

open access: yesBiomed Opt Express
Janssen S   +10 more
europepmc   +1 more source

Cochlear Implant Complications and Outcomes: National Trends of the MAUDE Database From 2016 to 2024

open access: yesOtolaryngology–Head and Neck Surgery, Volume 175, Issue 2, Page 444-452, August 2026.
Abstract Objective As cochlear implant (CI) use expands, complications have become a growing concern. While prior studies analyzed CI failures, few have comprehensively assessed national complication temporal patterns and clinical outcomes. This study evaluates patient and device complication patterns and outcomes from 2016 to 2024.
Daniel R. S. Habib   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy